BioSpace News Archive

BioCapital

NextCure to Host Virtual R&D Update Event on March 4, 2021

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, announced that it will host a Virtual R&D Update Event at 5:00 p.m. ET on Thursday, March 4.

February 26, 2021

·

3 min read

Business

NANOBIOTIX 2020 Q4 and Annual Revenues

NANOBIOTIX (Euronext : NANO – NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced its revenues for the fourth quarter and full year ended December 31, 2020.

February 26, 2021

·

8 min read

Deals

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 26, 2021

Cytokinetics, Incorporated announced that on February 26, 2021 it granted stock options to purchase an aggregate of 9,000 shares of common stock to Wing Keung Chiu, a new employee whose employment commenced in February 2021 as a material inducement to his employment.

February 26, 2021

·

3 min read

BioMidwest

Akorn Announces Review of Strategic Alternatives for the Akorn Consumer Health Business

Akorn Operating Company LLC, a leading specialty pharmaceutical company, announced that it is commencing a review of strategic alternatives for its Consumer Health business.

February 26, 2021

·

2 min read

Business

Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer

Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced the promotion of Crystal Muilenburg from VP, Corporate Communications & PR to Chief Marketing Officer effective today.

February 26, 2021

·

4 min read

Business

Rational Vaccines names Dr. Konstantin Kousoulas Vice President of Scientific Affairs

Leading virologist Konstantin “Gus” Kousoulas joined Rational Vaccines as vice president of Scientific Affairs where he will work to further the company’s core mission of eradicating the world of the herpes simplex virus (HSV), the company announced today.

February 26, 2021

·

2 min read

Drug Development

Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides additional study details for its ongoing Phase 2 clinical trial assessing Brilacidin as a novel therapeutic in hospitalized patients with COVID-19.

February 26, 2021

·

7 min read

BioCapital

Supernus to Present at Cowen Healthcare Conference

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals,

February 26, 2021

·

1 min read

BioLife Sciences Inc. (OTCPK:BLFE) Announces the Launch of Their New Copper Infused Face Masks

BioLife Sciences (OTCPK: BLFE) announces the launch of their Copper-Infused Face Masks to provide consumers with the long-lasting health and protective benefits of antimicrobial copper, which is infused throughout the fabric using NanoFusion Technology

February 26, 2021

·

2 min read

Biotech Bay

Model N to Present at the JMP Securities Technology Conference

Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that Jason Blessing, president and chief executive officer, and John Ederer, chief financial officer, will present at the following virtual investor conference

February 26, 2021

·

1 min read